DPC a Year Later … “Brothers in Medicine” — The Izbicki Brothers in Erie, PA

Direct Primary Care: A Journey Based in Faith, Trust, and Loyalty! Happy Anniversary to Our Patients, who have made Direct Primary Care success in Erie, PA By Drs. Jon & Harry Izbicki, DPC Journal Special Contributors OCTOBER 1, 2014 – When you have exhausted all possibilities, remember this: You haven’t. – Thomas Edison. One year ago, we began a historic journey in the world of medicine and … Continue reading DPC a Year Later … “Brothers in Medicine” — The Izbicki Brothers in Erie, PA

DPCJ Poll: What Is The Most Common Objection From People When Trying To Persuade/Educate Them About A DPC Practice?

(C) The Direct Primary Care Journal, October 2014; The Collective, Oct. 2014. All Rights Reserved. This content may not be reproduced or distributed without express written consent of The DPC Journal Editors. Continue reading DPCJ Poll: What Is The Most Common Objection From People When Trying To Persuade/Educate Them About A DPC Practice?

Study: Office Plants Can Boost Productivity and Morale

By Geoff Weiss, Entrepreneur Magazine October 1, 2014 – Getting your office into a vegetative state, it turns out, can actually be good for business. A new study out of the University of Queensland in Australia has concluded that an office ornamented with plantlife can actually increase employee productivity by 15 percent. “A green office communicates to employees that their employer cares about them and … Continue reading Study: Office Plants Can Boost Productivity and Morale

WSJ: As Doctors Lose Clout, Drug Firms Redirect the Sales Call

At Big Hospital Systems, Salespeople Woo Administrators to Get on ‘Formulary’ By Jonathan D. Rockoff Sept. 24, 2014 — SAN DIEGO— Kendall French used to pitch drugs to doctors who could prescribe them. But many of those doctors now work for hospitals that don’t give them final say over what is on the menu of medicines they can pick. So when the GlaxoSmithKline GSK.LN -0.53% … Continue reading WSJ: As Doctors Lose Clout, Drug Firms Redirect the Sales Call